The group around Ren LAI identified a is a KGD (Lys-Gly-Asp)-containing peptide (Vasotab TY) which binds to the fibrinogen receptor GPIIb/IIIa and has potent anti-thrombotic effects.

CAS news release, July 21, 2014

Gansu is China’s largest region for deer breeding. Deer peptides were found to lower blood pressure and have anti-fatigue effects. A process was developed to extract these peptides in high yields, enabling daily processing of 100 kg deer (blood?).

CAS news release, July 18, 2014

In collaboration with the CAS Shenzhen Institute of Advanced Technology, the second generation device is based on a more sophisticated artificial intelligence technology and directed towards patients with spinal cord injury and hemiplegia and paraplegia patients

CAS news release, July 16, 2014

Based on a special budget, the focus will be on the screening of oil-producing microorganism, strain improvement, large-scale cultivation process design and optimization, product separation and comprehensive utilization of industrial core issues.

China Bio news release, July 16, 2014

According to China’s National Energy Board, by 2020 3,5 – 4 million tons of biomass will be used for bioethanol production, biodiesel will reach 1 million tons, and aviation biofuel will reach 100000 t.

China Bio news release, July 15, 2014

Based on over 2 million tons per year of waste oil and oilplant production on marginal land, CAAS has awarded the 2014 1st prize for technology achievements to a group of institutes which have achieved 12 national patents on biodiesel production based on various pre-treatment technologies, efficient conversion technologies and supporting engineering technology at high efficiency and low cost.

China Bio news release, July 15, 2014

The group of Guanghui MA used PEI and PGMA-DVB gigaporous polymers of 300 – 500 nm pore size for the separation of proteins such as bovine serum albumen. Protein recovery was > 90 %, and, after tuning NaCl concentration, flow rate was over 1 m/hr.

CAS news release, July 17, 2014

The Chinese branch oft he joint center will be operated by CAS Institute of Genetics and Developmental Biology in Beijing and the Shanghai Institute of Plant Physiology and Ecology in Shanghai, and focus on crop improvement and diseases resistance. The Chinese partners will contribute 5 million £, the Bristish partners 3 million £ over 5 years

CAS news release, July 11, 2014

The group around Liping ZHAO studied intestional bacteria negatively correlated with disease indicators. A focus was on probiotic bacteria producing acetic acid in the gut, thus improving the function of the intestinal barrier.

China Bio news release, July 11, 2014

Based on studies on the mechanism of action, the group around Qiaoming JIANG produced modified nisins which could be produced in high yields and were less toxic.

China Bio news release, July 11, 2014

SFDA has permitted clinical trials for the therapy of systemic lupus erythematosus using human umbilical cord-derived mesenchymal stem cells.

Nikkei Biotech, July 10, 2014

As announced by COFCO, one of the few companies allowed to import corn, there are 12 kinds of GEM corn allowed into use in China, among which 6 were are from Syngenta: insect-resistant maize MIR604, herbicide-resistant maize GA21, insect resistance and herbicide tolerance corn Bt11 × GA21, insect-resistant maize Bt11, insect-resistant maize Bt176, quality improvement corn 3272.

China Bio news release, July 10, 2014

Sapphire energy produces algal in a pilot plant in New Mexico. The target is to build a large demonstration facility in a “refinery setting” in China. The project has ben selected for the US-China EcoPartnership program.

Sapphire Energy news release, July 10

The commercial production is done by the CAS Microbial Institute of Shaanxi, starting from lysine-producing strains, and a local manufacturer. The use of this product will be in nylon 512, using dodecanoic diacid produced by Candida strains.

China Bio news release, July 9, 2014

The partners involved are the Zhongshan Ophtalmic Center, Liu YI, and the Human Genome Research Institute, San Diego, Kang ZHANG. The focus is on the regulation of limbal stem cell differentiation and PAX6 WNT7A as a key factor in corneal lineage differentiation.

China Bio news release, July 9, 2014

The group around Pingshu TANG has succeeded to inbreed minipigs to a high level of homozygosity, allowing for enhanced porcine xenograft standards. The minipigs will serve as models for human diseases, for drug analysis, and in future for cornea and liver xenotransplantation.

China Bio news release, July 9, 2014

The “enzymatic biodiesel” project will be supported by Tsinghua University’s Innovation Center in Dongguan, located close to Humen.

China Bio news release, July 8, 2014

The technology, developed by Zhiying YAN, is based on an inexpensive culture of Lactobacilli provided as a liquid or freeze-dried culture which can be applied to dump toilets. It is less suitable for flush toilets

CAS news release, July 8, 2014

According to China’s Gene Agricultural Network, 4.2 million ha were planted with transgenic cotton, 90 % of total (2013). Transgenic papaya was planted on 4.500 ha in 2013.

China Bio news release, July 7, 2014

Based on the improved use of growth factors, bone repair materials having collagen-binding ability were developed which will allow to enter production by next year.

Chine Bio news release, July 7, 2014